South Africa’s health regulator approves ‘innovative’ HIV-prevention injection.
--:--
South Africa’s health regulator approves ‘innovative’ HIV-prevention injection
The South African Health Products Regulatory Authority has authorised an injection containing the antiretroviral cabotegravir to prevent HIV infection.
A duo of large clinical trials found that people who were given an injection of the antiretroviral cabotegravir every other month were about 80% less likely to contract HIV than those on the HIV-prevention pill.
The South African Health Products Regulatory Authority (Sahpra) has authorised an injection containing the antiretroviral cabotegravir for use to prevent HIV infection, according to drugmaker ViiV Healthcare.
The South African Health Products Regulatory Authority has authorised an injection containing the antiretroviral cabotegravir to prevent HIV infection.
A duo of large clinical trials found that people who were given an injection of the antiretroviral cabotegravir every other month were about 80% less likely to contract HIV than those on the HIV-prevention pill.
The South African Health Products Regulatory Authority (Sahpra) has authorised an injection containing the antiretroviral cabotegravir for use to prevent HIV infection, according to drugmaker ViiV Healthcare.
